Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | BMY | AMGN | GILD | REGN |
| Company | Intra-Cellular Ther | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 72.46 | 47.39 | 273.45 | 67.47 | 911.09 |
| High | 72.78 | 47.50 | 274.35 | 67.90 | 915.00 |
| Low | 71.35 | 44.37 | 267.24 | 65.09 | 876.75 |
| Last | 72.13 | 44.70 | 269.38 | 65.27 | 890.68 |
| Change | -0.99 | -4.16 | -3.63 | -1.81 | -15.86 |
| % Change | -1.35% | -8.51% | -1.33% | -2.70% | -1.75% |
| Volume | 658,700 | 45,069,000 | 1,794,000 | 15,171,900 | 576,500 |
| 20-Day Average Volume | 1,396,240 | 12,858,680 | 2,149,590 | 6,861,755 | 454,910 |
| Previous Close | 73.12 | 48.86 | 273.01 | 67.08 | 906.54 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 70.20 | 49.94 | 270.70 | 68.68 | 922.51 |
| 20-Day Raw Stochastic | 38.46% | 3.27% | 31.20% | 2.05% | 14.81% |
| 20-Day Relative Strength | 53.35% | 28.31% | 44.80% | 28.32% | 34.96% |
| Weighted Alpha | +21.57 | -34.75 | +9.12 | -23.73 | +11.12 |
| Today's Opinion | 100% Buy | 88% Sell | 72% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 100% Buy | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 56% Buy | 8% Sell | 24% Buy | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.18% since 04/18/24 | -7.45% since 04/18/24 | +2.52% since 04/18/24 | -1.35% since 04/18/24 | -0.37% since 04/18/24 |
| Low | 70.93 on 04/19/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 876.75 on 04/25/24 |
| High | 76.89 on 04/23/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 920.73 on 04/19/24 |
| 1-Month | |||||
| %Chg | +6.12% since 03/25/24 | -14.45% since 03/25/24 | -4.07% since 03/25/24 | -10.07% since 03/25/24 | -7.33% since 03/25/24 |
| Low | 64.15 on 04/15/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 876.75 on 04/25/24 |
| High | 84.89 on 04/16/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | +7.69% since 01/25/24 | -9.90% since 01/25/24 | -13.18% since 01/25/24 | -18.65% since 01/25/24 | -6.13% since 01/25/24 |
| Low | 62.78 on 02/22/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 876.75 on 04/25/24 |
| High | 84.89 on 04/16/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +49.03% since 10/25/23 | -21.04% since 10/25/23 | -1.02% since 10/25/23 | -16.74% since 10/25/23 | +11.75% since 10/25/23 |
| Low | 45.50 on 10/30/23 | 44.37 on 04/25/24 | 249.70 on 10/31/23 | 65.09 on 04/25/24 | 769.19 on 10/27/23 |
| High | 84.89 on 04/16/24 | 55.29 on 10/26/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 7,078,528 | 99,027,448 | 146,436,016 | 83,519,768 | 99,503,640 |
| Shares Outstanding, K | 96,807 | 2,026,759 | 536,376 | 1,245,077 | 109,762 |
| Annual Sales | 464,370,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -139,670,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 132,100,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -28,580,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.02 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.30 on 02/22/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.53 | 14.67 | 9.97 | 24.14 |